Recent studies have shown that aberrantly expressed gastrin-releasing peptide (GRP) and its receptor (GRP-R) critically regulate tumor cell differentiation in colon cancers developing in humans and mice. This finding suggested that the ability of GRP/GRP-R to promote a welldifferentiated phenotype in colon cancer might reflect a re-capitulation of a normal role in regulating intestinal organogenesis. To determine if this was the case, we compared and contrasted intestinal development in GRPR 2/2 mice with their wild type littermates. GRP/GRP-R coexpression in wild type mice was only observed in villous enterocytes between N-1 and N-12. During this time frame villous growth was completely attenuated in GRPR 2/2 mice. The contribution of GRP/GRP-R to villous growth was due to their act in increasing enterocyte proliferation prior to N-8 but increasing enterocyte size thereafter. From N-12 onwards, small intestinal villous growth in GRPR 2/2 mice resumed such that no difference in this structure could be detected at adulthood between mice of either genotype. We next studied GRP/GRP-R expression in human abortuses. These proteins were co-expressed by villous enterocytes only between weeks 14 and 20 post-conception, a time frame analogous to when they are expressed in the murine intestine. Thus, this study shows for the first time that GRP/GRP-R play a transient and non-critical role in intestinal development, yet provides a rationale for their re-appearance in colon cancer. q
Introduction
Gastrin-releasing peptide (GRP) is widely expressed by enteric nerves lining the gastrointestinal (GI) tract of all mammals studied to date (Kato et al., 1991) . GRP regulates a number of normal physiological responses within the GI tract including altering smooth muscle contractility (Jensen et al., 1988; Severi et al., 1991) , regulating the secretion of the exocrine pancreas (Jensen et al., 1988) , and influencing the release of other GI peptide hormones (Ghatei et al., 1982) . GRP mediates its effects by binding to a specific 7 transmembrane-spanning G protein coupled receptor that has been cloned and sequenced in humans (Corgay et al., 1991) and mice (Spindel et al., 1990; Battey et al., 1991) .
Except for neuroendocrine cells within the gastric antrum, epithelial cells lining the mature human or murine GI tract do not normally express GRP or its receptor (Preston et al., 1995; Ferris et al., 1997; Carroll et al., 1999b) . In contrast, we (Carroll et al., 1999a (Carroll et al., ,b, 2000b and others (Radulovic et al., 1992; Preston et al., 1995; Saurin et al., 1999) have shown that many GI cancers aberrantly secrete GRP as well as express binding sites for this ligand and/or its pharmacological homologue bombesin. Stimulation of these GRP receptors (GRP-R) results in tumor cell proliferation as well as causes them to adopt a better-differentiated phenotype. Hence, GRP is both a mitogen and a morphogen in the context of at least colon cancer (Carroll et al., 1999b (Carroll et al., , 2000a . Since GRP/GRP-R contribute to colon cancer differentiation, we hypothesized that their expression in cancer possibly re-capitulated -albeit dysfunctionally -a role in normal intestinal development. To determine if this could be the case, we studied intestinal development in GRPR 2/2 mice, their wild type littermates, and in phenotypically normal human abortuses. We herein report that GRP/GRP-R are transiently expressed by enterocytes lining the villi of both the human and mouse intestine. By comparing and contrasting development in GRPR 2/2 and wild type mice, we demonstrate that GRP contributes equally to enterocyte proliferation and size. Thus, this hormone's ability to act as a mitogen and a morphogen in colon cancer re-capitulates its normal behavior during gut organogenesis.
Results

Timing of GRP and GRP-R intestinal expression
GRP was not expressed in the pseudostratified epithelium of the intestine prior to villus development at E-14 (Fig. 1A) but could be detected after villus development at E-17. When present, GRP chromogen concentration was highest in the middle to top third of each villus (Fig. 1B) , with similarly high levels of expression noted between E-17.5 and N-12 (Table 1) . From N-12 onwards, decreased amounts of GRP were detectable such that none was observed by N-21 (Table 1 ; Fig. 1C ). Importantly, whereas GRP expression extended to the villous base prior to crypt development ( Fig. 2A) , this protein was never identified within crypts, a structure that was present in the small intestine from N-8 onwards (Fig. 2C) . Finally, the amount, kinetics, and location of GRP expression was identical in wild type and GRPR 2/2 mice (data NS). GRP-R expression in the developing wild type mouse small intestine was more circumscribed. GRP-R was never detected in intestinal epithelial cells in utero (Fig. 1D) , but was observed immediately after parturition in mice with gastric milk present (i.e. N-1). Maximal GRP-R expression was observed at N-4 ( Fig. 1E ; Table 1 ). GRP-R immunoreactivity then disappeared from villus base to tip starting around N-8, and was completely undetectable by N-21 ( Fig.  1F ; Table 1 ). Similar to GRP, GRP-R expression was greatest in the middle to top two-thirds of each villus in wild type mice (Figs. 1E and 2C; Table 1), while this protein was never detected in crypts. In contrast, GRP-R immunoreactivity was never found in any part of the intestines of Fig. 1 . GRP (panels A-C) and GRP-R expression (panels D-E) in epithelial cells lining the small intestine of wild type C57BL/6J mice. Expression of GRP (panel A) and GRP-R (panel D) was not evident in the pseudostratified epithelium of the newly developing intestine at E-14. When present, GRP (panel B) and GRP-R (panel E) was observed only in epithelial cells lining the villi as shown for wild type mice aged N-8. By N-21, however, neither GRP (panel C) or GRP-R (panel F) could be detected. Images were acquired at 40 £ (panels A,D) or 400 £ (all other panels) after performing immunohistochemistry as described in Section 4. 
2/2 mice (data NS). Thus, GRP/GRP-R co-expression in the murine small intestine was limited to villi of wild type mice aged between N-1 and N-12. Similar to what has been previously described (Quaroni and Calnek, 2000) , villi were also found in the mouse colon, albeit transiently, from N-1 to N-6. Both GRP and GRP-R were detectable immunohistochemically in villi lining the colons of wild type mice (Table 1) . For the entire time this structure was present, and similar to what was observed in the small intestine, GRP/GRP-R were not detected in the crypts; while the colonic villus expression of GRP was identical in GRPR 2/2 mice as in wild type animals.
Early villous growth requires GRP/GRP-R
At N-1, the time at which GRP/GRP-R co-expression was first observed, small intestinal villi were equally sized in GRPR 2/2 and wild type mice. Thereafter, villi from both the proximal and distal small intestine in wild type mice linearly increased in size from E-17.5 until adulthood at N-42. In contrast, and despite the fact that both proximal and distal villi were identically sized at the time of parturition (N-1) in both wild type and GRPR 2/2 mice, there was nearcomplete villous growth arrest in mice lacking the GRPR gene until N-12 (Fig. 3) . This resulted in proximal villi being 35^6% smaller, and distal villi 30^3% smaller, in GRPR 2/2 mice at age N-12 than what was observed in their wild type littermates. From N-12 onwards, however, the time point at which GRP/GRP-R were no longer co-expressed in wild type mice (Table 1) , villous growth resumed in GRPR 2/2 mice such that no difference in villous size could be detected in adult mice of either genotype (Fig. 3) .
Villi are known to be transiently present in the mouse colon until age N-6 (Quaroni and Calnek, 2000) . Colonic villi are significantly larger than those present in the small intestine, although total numbers are significantly less. This vestigial structure is maximally sized at parturition, at which point they rapidly regress. Similar to what was observed for villi lining the small intestine, GRP/GRP-R co-expression was only observed in colonic villi from N-1 onwards. Unlike the small intestine, however, no difference in villous size could be detected in wild type versus GRPR 2/2 mice (Fig. 3 ). Overall, GRPR 2/2 males gained weight at rates similar to their wild type littermates. Indeed, no difference in crypt or mucin cell development could be identified between the two genotypes at any point during intestinal maturation in the newborn. With the sole exception of villus size, no other demonstrable difference between wild type and GRP-R 2/2 mice was detected.
Proliferation differences in wild type and GRP-R
2/2 mice Exogenous GRP administration has previously been shown to augment intestinal DNA synthesis in the suckling rat (Kaouass et al., 1977) ; while GRP is well established as a mitogen when it and its receptor are aberrantly expressed by cancers of the GI tract (reviewed in Jensen et al., 2001 ). We therefore studied intestinal proliferation rates in mice of either genotype in order to determine if the absence of receptor in GRP-R 2/2 mice was associated with a decrease in the number of dividing cells.
Prior to the development of crypts, metaphase-arrested ( Fig. 2C ) and proliferating cell nuclear antigen (PCNA)-positive (data NS) cells in wild type mice were restricted to the base of individual villi. During this time frame, significant amounts of GRP and GRP-R chromogen could be detected at the villous base of wild type mice ( Fig. 2A) . Also during this period, significantly higher proliferation rates were observed in wild type (8.0^1.0 metaphases) as compared to GRP-R 2/2 mice (3.6^0.8 metaphases, P , 0:05) (Fig. 4) . However, this difference disappeared with the development of crypts and the restriction of proliferating cells to that compartment.
Crypts were first identifiable at N-6, and were invariably associated with villi by N-8. As soon as crypts were present, proliferating cells were only found in that structure (Fig.  2D) . In contrast to what was observed from N-2 to N-6, identical numbers of proliferating cells were detected in the crypts of wild type mice (7.4^0.9 metaphases) as compared to GRPR 2/2 mice (6.5^1.1 metaphases) aged N-8 to N-12 (Fig. 4) . This is important since GRP/GRP-R expression was never detected within a crypt (Fig. 2C ). Since the rates of enterocyte apoptosis were ,1% and equal between mice of either genotype, differences in villous size at least prior to crypt development at N-8 appear to be due to differences in cell number.
In contrast, the difference in villous size between wild type and GRPR 2/2 mice between N-8 and N-12 -when the number of proliferating cells contained in the crypts was identical -cannot be due to differences in enterocyte number. To determine if GRP/GRP-R also influenced cell size, given their role as morphogens, we next determined cell size in mice of either genotype. To do this we measured enterocyte sizes by forward scatter of FACS-sorted enterocytes. At N-8, enterocyte proliferation rates in wild type and GRPR 2/2 mice are approximately equal (Fig. 4 ) whereas their size differs by ,35% (Fig. 3) . Mean forward scatter was ,40% greater in enterocytes isolated from wild type as compared to GRPR 2/2 mice (Fig. 5 ). Thus differences in enterocyte proliferation account for the differences in villous size prior to N-8, most if not all of the total increase in villous size between N-8 and N-12 in wild type mice can be attributed to increased enterocyte size.
GRP/GRP-R expression in human fetal intestine
Given the modest and transient effect of GRP on murine villous growth, the effect could be argued as unimportant and irrelevant to that which occurs in other species including humans. We therefore studied GRP/GRP-R expression in human embryos ,9-21 weeks in gestational age. Similar to mice, GRP/GRP-R expression was transient, detected only between 14 and 20 weeks of development (Fig. 6) . The timing of this expression, therefore, is similar between Fig. 3 . Villus size in wild type C57BL/6J mice (closed symbols) and their GPR-R 2/2 littermates (open symbols). Villus size was determined in proximal small intestine (left panel), distal small intestine (middle panel) and proximal colon (right panel) as described in Section 4. Villus size is expressed in pixels and was determined using images acquired digitally at 1000 £ . ( p ) Indicates value is significantly different ðP , 0:05Þ as determined using the paired t-test, with data represented as means^SEM. 
Discussion
In this study, we demonstrate that GRP-R expression has a significant albeit transient effect on villus development in the newborn mouse, and that this expression occurs during a time period corresponding to that observed in humans. Furthermore, we show that GRP has two different effects during this time frame. Prior to crypt development at N-8, GRP acts primarily to increase villous size by acting as a mitogen and increasing enterocyte number. Between N-8 and N-12, however, proliferating cells are restricted to the crypts, a region that does not express GRP/GRP-R. Rather, during this time period GRP acts to increase enterocyte size.
The subsequent normalization of villous size observed in GRPR 2/2 mice after N-12 (Fig. 3) identifies a GRP-independent phase of villus development that is controlled by other factors, possibly including TGF-a and IGF-2 (reviewed in Henning, 1985) , that can compensate and correct for the initial lag in growth. Thus, GRP's autocrine/paracrine effects are not only transient but also nonessential to mediating normal gut development.
Despite the non-essential role of GRP and its receptor play in regulating intestinal development, our observations nonetheless remain important. GRP/GRP-R are aberrantly expressed by many cancers including those arising in the colon, lung and prostate (reviewed in Jensen et al., 2001 ).
Fig. 5. Representative FACS analysis of intestinal enterocytes isolated from GRPR
2/2 (left panel) and wild type (right panel) mice aged N-8. Enterocytes were isolated as described in Section 4, and forward scatter measured for a minimum of 30,000 separate events. Data points contained within the white ellipsoid contain two-thirds of the scanned cells, and represents the most homogenous population present. Forward scatter is measured using arbitrary units, and represents a measure of mean cell size.
Fig. 6. GPR-R expression in intestinal epithelial cells lining the human small intestine aged 9 weeks (panel A), 14 weeks (panel B), and 21 weeks (panel C).
Embryos were isolated and intestinal tissues processed as described in Section 4. Immunohistochemical evidence of GRP-R and GRP (data NS) was restricted to enterocytes lining small intestinal villi aged 14-20 weeks, with age determined from maternal estimated dates of conception and confirmed by crown-rump length measures at autopsy.
In all instances, GRP/GRP-R are only expressed by betterdifferentiated malignancies, giving rise to the hypothesis that this protein and its receptor are important in regulating tumor cell differentiation. If this is the case, GRP/GRP-R re-expression in cancer should be re-capitulating -in an admittedly dysfunctional manner -its normal role during organogenesis regardless of how minor that contribution might be. That this is likely the case has already been demonstrated in the context of lung development and small cell cancer of the lung (SCCL).
GRP-R are not normally expressed by epithelial cells lining the mature airway, whereas they are aberrantly expressed by all well-differentiated (but not poorly differentiated) SCCL (Carney et al., 1985; Nakajima et al., 1986; Kado-Fong and Malfroy, 1989) . Because of this difference in expression as a function of differentiation, GRP-R upregulation likely re-capitulates a normal role in pulmonary organogenesis. Indeed, epithelial cells lining lung buds of the distal airway of both mice and rabbits transiently express GRP-R just prior to terminal differentiation (King et al., 1995; Wang et al., 1996) . In vivo these receptors are activated by GRP secreted by adjacent neuroendocrine cells; when these buds are cultured ex vivo, exogenous administration of the GRP agonist bombesin increases lung bud branching (King et al., 1995; Wang et al., 1996) .
Based on our prior observation that GRP/GRP-R coexpression is only observed in better differentiated colon cancers in humans (Carroll et al., 1999b) , and that colon cancers progressively de-differentiate in GRPR 2/2 mice (Carroll et al., 2000a) , we proposed that these proteins act as tumor morphogens when aberrantly expressed in cancer (Jensen et al., 2001) . In cancer, morphogens have been described as proteins that promote tumor differentiation (Tahara, 1993) . Development and cancer have been viewed by some as linked processes in which the disruption of the regulated expression of proto-oncogenes in organ development leads to a characteristic malignant phenotype in adult tissue transformed by carcinogens (Rubin, 1985; Ohlsson and Pfeifer-Ohlsson, 1987) . Indeed, an early author defined the products of these genes as onco-fetal proteins and stated that 'oncogeny is blocked ontogeny' (Potter, 1969) . From the present study, we conclude that the ability of GRP/GRP-R to promote a well-differentiated phenotype when aberrantly expressed in colon cancer reflects the normal developmental role these proteins play in intestinal maturation. Efforts to understand the role and regulation of this neuropeptide hormone receptor and its ligand in either arena may advance our understanding of both of these complex growth processes.
Methods
Materials
Breeding pairs of C57Bl/6J mice lacking the GRPR gene were established as previously described (Hampton et al., 1998; Carroll et al., 2000a) ; with only male mice used in this study in order to minimize potential hormonal influences. Since the murine GRPR gene resides on the X chromosome heterozygote male animals could not be studied. The University of Illinois at Chicago Animal Care Committee approved this study, and all care was provided in accordance with institutional guidelines.
Immunohistochemical supplies were from DAKO (LSAB System; Carpinteria, CA, USA), Vector Labs (DAB; Burlingame, CA, USA), Kirkegaard and Perry (goat serum; Gaithersburg, MD, USA), or Fisher Scientific (all other reagents; Pittsburgh, PA, USA). Antibody for GRP was a gift from Dr Thomas McDonald (University of Western Ontario, London, Canada), while all other materials including Schiff's reagent and vincristine were from Sigma (St. Louis, MO, USA).
Collection and processing of murine intestinal tissues
Pregnancy was established by observing cervical plugging, with embryonic age dated from noon of that day (Silver, 1995) . Late embryos were harvested from pregnant mice euthanized by CO 2 asphyxiation whereas newborns were sacrificed by decapitation. Adult mice were studied at age of 6 weeks (N-42) and were sacrificed by CO 2 asphyxiation. All mice from age N-2 onwards received 1 mg/kg vincristine intraperitoneally 2 h prior to sacrifice in order to arrest dividing intestinal cells in metaphase. Viscera were removed under direct stereomicroscopic visualization, fixed in buffered formalin, and embedded in paraffin. Gender was determined at the time of sacrifice by the identification of a bicornuate uterus or testes. At the time of sacrifice ,1 cm tail was removed and flash-frozen in liquid N 2 to allow genotyping as described below.
Animal genotyping
Tail DNA was isolated using the Easy-DNA kit (Invitrogen, Carlsbad, CA, USA) according to manufacturer's instructions. Genomic DNA was resuspended in 50 ml milliQ water and incubated with 2 mg/ml RNase for 60 min at 378C. Polymerase chain reaction (PCR) analysis was performed using 100 ng primers #1 (5 0 -GCTCATTCCTCCCACT-CATG-3 0 ) and #2 (5 0 -CATCTCTCGTGGGATTG-3 0 )
combined with 1 mg tail DNA in a 30 cycle reaction (denature, 958C £ 30 s; anneal, 558C £ 30 s; extension, 728C for 1 min). A second amplification reaction was performed with 5% of the first PCR reaction using nested internal primers #3 (5 0 -CTGCCAAATAGCCACCTGTG-3 0 ) and #4 (5 0 -AG-CCAGGTACTTGCTGGCAT-3 0 ) under the same conditions. This second reaction generated a 380 bp PCR product when genomic DNA containing a neomycin resistance gene found only in the targeted GRPR allele was present.
Quantitative immunohistochemistry
Detection of GRP and GRP-R protein was performed using a three-stage indirect immunoperoxidase technique similar to what we have previously described (Carroll et al., 1999b) . Briefly, 5 mm-thick tissue sections were heatfixed, rehydrated in graded ethanols, and then rinsed in a running water bath. Endogenous peroxidase activity was quenched by incubating slides in 3% H 2 O 2 for 15 min, then 50% methanol for 15 min, followed by 10% goat serum for 20 min. Primary antibodies for GRP (Fraser et al., 1994; Carroll et al., 1999b) and GRP-R (Kroog et al., 1995; Carroll et al., 1999b) were applied at a dilution of 1:500 for 30 min in a humidity chamber. Labeling of bound antibody was performed by incubating with streptavidin conjugated to horseradish peroxidase for 15 min followed by treating with diaminobenzidine for 2 min. Tissues were counter-stained with a 50% dilution of Gill's modified hematoxylin for 1 min and then coverslipped using Permount.
Chromogen was quantified as previously described (Matkowskyj et al., 2000) . Briefly, images were acquired at 1000 £ using a 9 million pixel Microlumina Ultra Resolution digital screening camera (Leaf Systems, Ft. Washington, PA, USA). Representative 100 £ 100 pixel regions were isolated from the top, middle and bottom third of each villus studied, as well as from the adjacent crypt when present. The cumulative signal strength was determined for each image file, with the amount of antibodyspecific chromogen determined by subtracting the mathematical energy of the control image (i.e. not exposed to primary antibody) from that of the 'experimental' image (i.e. exposed to primary antibody). Chromogen quantity is expressed in the unit-less values of energy units per pixel (eu/pix) (Matkowskyj et al., 2000) .
Morphometric analysis
Villus size was determined by studying a minimum of three mice of known genotype at each time point. For each animal, a minimum of three consecutive 5 mm-thick sections were evaluated after staining with hematoxylin and eosin (Allen, 1992) . From each section at least ten separate images were acquired at 100 £ , with villous size measured in pixels using the lariat function in PhotoShop (Adobe, San Jose, CA, USA). Per image, 20 separate villi were outlined and the pixel number contained therein determined. Only villi containing a completely intact central lymphatic core were used for measurement. To determine the number of cells per villus, we counted all nuclei present in a mid sagittal villus section. Finally, villus density was determined by counting all villus cross-sections visible in three representative 400 £ images.
Cellular proliferation analysis
Proliferation was determined by two different techniques: counting vincristine-arrested metaphase nuclei as well as nuclei staining positively for PCNA. In the former technique, mice were injected with 1 mg/mg vincristine 2 h prior to sacrifice, the crypts freshly dissected, and metaphase arrested nuclei counted (Goodlad, 1994) . Briefly, representative sections of intestine were fixed in Carnoy's solution for 3 h and stored in 70% ethanol. Tissues were prepared for study by hydrating in graded ethanols, immersed in 1 M HCl for 10 min at 608C, and then counter-stained with Schiff's reagent for 40 min. Individual villi and their attached crypts were isolated under direct stereomicroscopic vision after adding two drops of 45% (v/v) acetic acid, followed by gently spreading under a large coverslip. Metaphase nuclei from 20 separate villi or crypts were identified at 400 £ and counted. This approach was confirmed by staining representative sections with PCNA as previously described (Carroll et al., 1999b) .
Finally, cellular apoptosis rates were determined using the DeadEnd Colorimetric Apoptosis Detection System (Promega, Madison, WI, USA), a modified TUNEL assay. Total apoptotic cells per high powered field (HPF, 400 £ ) were counted and averaged for a minimum of 10 HPF/specimen.
Villous enterocyte isolation and FACS sorting
Individual villous enterocytes were isolated from the intestines of N-8 littermates -whose individual genotype was determined by tail PCR -using a modification of the method of Weiser (Jacobson et al., 1987) . Briefly, the small intestine was isolated and flushed with 0.154 M NaCl/1 mM DTT solution. The entire intestine was then filled via a blunt cannula with Joklik's media with 5% fetal calf serum, ligated at both ends with silk suture, and incubated in a 378C water bath for 10 min. The intestine was drained and then filled with a phosphate buffered citrate solution to dissociate epithelial cells (27 mM citrate, 96 mM NaCl, 1.5 mM KCl, 8 mM KH 2 PO 4 , 5.6 mM Na 2 HPO 4 , pH 7.3) and incubated at 378C for 15 min. This is followed by a second incubation with EDTA in a calcium and magnesium free solution (1.5 mM EDTA/0.5 mM DTT in phosphate buffered 0.9% NaCl) for 10 min. Harvested cells were washed, resuspended in 400 ml PBS, and filtered through a 10 mm filter. Immediately thereafter cells were injected into a FACS Calibur flow cytometer containing a 488 nm argon ion laser. Forward scatter measurements were made on gated samples with a minimum of 20,000 events per run. This method isolates only epithelial cells and not serosal or interstitial cells. H&E staining of an aliquot of cells isolated from each animal confirmed the uniformity of the cell population.
Study of developing human intestine
Human embryos of gestational age 10-22 weeks were obtained after therapeutic termination of pregnancy. Fetal tissue was immediately placed in 10% buffered formalin for 4-12 h, the abdomen opened and the developing intestine removed in toto and kept in formalin for another 24 h, and then placed in a Miles Scientific Tissue-Tek VIP bench-top automated tissue processor. After placement in paraffin, 5 mm-thick sections were processed immunohistochemically using antibodies to GRP and GRP-R as described above. Specimens were dated from maternal estimated dates of conception and confirmed by crown-rump length measurements at autopsy. The UIC Institutional Review Board approved this study.
